Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

ENZON PHARMACEUTICALS, INC. (ENZN)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K10-K10-K10-K
Total revenues   [+]0.70.10.26.98.48.417.531.2
            Revenue growth  1248.1%-74.9%-97.0%-17.4%0.0%-52.0%-44.0%-9.6%
Cost of goods sold  1.21.41.21.11.41.76.72.4
Gross profit  -0.5-1.3-1.05.97.06.610.828.8
            Gross margin  -66.9%-2509.6%-470.0%84.6%83.6%79.3%61.9%92.4%
Selling, general and administrative   [+]   1.11.41.72.2 
Research and development          
Other operating expenses       -1.7-6.7 
EBITDA   [+]        
Depreciation and amortization          
EBIT   [+]-0.5-1.3-1.04.85.66.715.328.8
            EBIT margin  -66.9%-2509.6%-470.0%69.3%67.3%80.0%87.7%92.4%
Interest income         0.1
Other income (expense), net   [+]0.00.0 1.11.4-0.1-4.5 
Pre-tax income  -0.5-1.3-1.05.97.06.610.828.9
Income taxes  0.00.00.00.01.67.8-10.80.1
            Tax rate     0.1%22.3%116.9% 0.2%
Net income  -2.5-1.8-1.05.85.4-1.121.628.8
            Net margin  -355.5%-3405.8%-472.9%84.5%65.0%-13.4%124.0%92.4%
   
Basic EPS   [+]($33.58)($34.66)($0.02)$0.13$0.12($0.03)$0.49$0.65
Diluted EPS   [+]($33.58)($34.66)($0.02)$0.13$0.12($0.03)$0.49$0.65
   
Dividends per share   [+]  $0.18 $0.15$0.15$0.85$0.10
   
Shares outstanding (basic)   [+]0.10.144.244.244.244.244.244.1
Shares outstanding (diluted)   [+]0.10.144.244.244.244.244.244.2
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy